The discrepancy between genetic polymorphism of p53 codon 72 and the expression of p53 protein in helicobacter pylori-associated gastric cancer in Korea

Digestive Diseases and Sciences

Volumn 55, Issue 1, 2010, Pages 101-110

  Kim, Nayoung ^a,b   Cho, Sung Il ^c   Lee, Hye Seung ^a   Park, Ji Hyun ^b   Kim, Jee Hyun ^a   Kim, Joo Sung ^b   Jung, Hyun Chae ^b   Song, In Sung ^b  

^a Seoul National University Bundang Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

Gastric cancer; Genetic polymorphism; Helicobacter pylori; P53

Indexed keywords

PROTEIN P53;

ADULT; AGED; ALLELE; ARTICLE; CANCER TISSUE; CODON; CONTROLLED STUDY; DISEASE ASSOCIATION; DUODENUM ULCER; DYSPLASIA; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KOREA; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER; STOMACH ULCER; GENE FREQUENCY; GENETICS; GENOTYPE; HELICOBACTER INFECTION; MICROBIOLOGY; MIDDLE AGED; MUTATION; PATHOLOGY; STOMACH MUCOSA; STOMACH TUMOR; TUMOR SUPPRESSOR GENE;

CODON; DUODENAL ULCER; FEMALE; GASTRIC MUCOSA; GENE FREQUENCY; GENES, P53; GENOTYPE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOHISTOCHEMISTRY; KOREA; MALE; MIDDLE AGED; MUTATION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; STOMACH NEOPLASMS; STOMACH ULCER; TUMOR SUPPRESSOR PROTEIN P53;

EID: 74049148510     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-008-0688-x     Document Type: Article

References (60)

1. AJ Levine 1992 The p53 tumor suppressor gene and product Cancer Surv 12 59 79 1:CAS:528:DyaK3sXjs1Ojtg%3D%3D 1638548
2. AJ Levine 1997 p53, the cellular gatekeeper for growth and division Cell 88 323 331 10.1016/S0092-8674(00)81871-1 10.1016/S0092-8674(00)81871-1 1:CAS:528:DyaK2sXhtFahtLg%3D 9039259 (Pubitemid 27131374)
3. T Shepherd D Tolbert J Benedetti J Macdonald G Stemmermann J Wiest G De Voe MA Miller J Wang A Noffsinger C Fenoglio-Preiser 2000 Alterations in exon 4 of the p53 gene in gastric carcinoma Gastroenterology 118 1039 1044 10.1016/S0016-5085(00)70356-8 10.1016/S0016-5085(00)70356-8 1:CAS:528: DC%2BD3cXktlaiurw%3D 10833478
4. YC Wang HS Lee SK Chen YY Chang CY Chen 1999 Prognostic significance of p53 codon 72 polymorphism in lung carcinomas Eur J Cancer 35 226 230 10.1016/S0959-8049(98)00369-4 10.1016/S0959-8049(98)00369-4 1:STN:280: DyaK1MznsleksQ%3D%3D 10448264 (Pubitemid 29136772)
5. R Birgander A Sjalander Z Zhou C Fan L Beckman G Beckman 1996 p53 polymorphisms and haplotypes in nasopharyngeal cancer Hum Hered 46 49 54 10.1159/000154325 10.1159/000154325 1:CAS:528:DyaK28XhtFyhs7Y%3D 8825463
6. K Kawajiri K Nakachi K Imai J Watanabe S Hayashi 1993 Germ line polymorphisms of p53 and CYP1A1 genes involved in human lung cancer Carcinogenesis 14 1085 1089 10.1093/carcin/14.6.1085 10.1093/carcin/14.6.1085 1:CAS:528:DyaK3sXkvFals7g%3D 8389669
7. X Jin X Wu JA Roth CI Amos TM King C Branch SE Honn MR Spitz 1995 Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotype Carcinogenesis 16 2205 2208 10.1093/carcin/16.9.2205 10.1093/carcin/16.9.2205 1:CAS:528:DyaK2MXot1ansL0%3D 7554076
8. EN Papadakis DN Dokianakis DA Spandidos 2000 p53 codon 72 polymorphism as a risk factor in the development of breast cancer Mol Cell Biol Res Commun 3 389 392 10.1006/mcbr.2000.0241 10.1006/mcbr.2000.0241 1:CAS:528: DC%2BD3cXotlGiuro%3D 11032762 (Pubitemid 30803131)
9. A Sjalander R Birgander G Hallmans S Cajander P Lenner L Athlin G Beckman L Beckman 1996 p53 polymorphisms and haplotypes in breast cancer Carcinogenesis 17 1313 1316 10.1093/carcin/17.6.1313 10.1093/carcin/17.6.1313 1:STN:280:DyaK283otFKqsw%3D%3D 8681448 (Pubitemid 26196343)
10. I Zehbe G Voglino E Wilander F Genta M Tommasino 1999 Codon 72 polymorphism of p53 and its association with cervical cancer Lancet 354 218 219 10.1016/S0140-6736(99)01914-5 10.1016/S0140-6736(99)01914-5 1:CAS:528: DyaK1MXltVWhtL0%3D 10421306 (Pubitemid 29329163)
11. A Storey M Thomas A Kalita C Harwood D Gardiol F Mantovani J Breuer IM Leigh G Matlashewski L Banks 1998 Role of a p53 polymorphism in the development of human papilloma virus-associated cancer Nature 393 229 234 10.1038/30400 10.1038/30400 1:CAS:528:DyaK1cXjtlymtLs%3D 9607760 (Pubitemid 28261713)
12. S Andersson E Rylander A Strand J Sallstrom E Wilander 2001 The significance of p53 codon 72 polymorphism for the development of cervical adenocarcinomas Br J Cancer 85 1153 1156 10.1054/bjoc.2001.2085 10.1054/bjoc.2001.2085 1:CAS:528:DC%2BD3MXoslamu7g%3D 11710828 (Pubitemid 33052314)
13. A Helland A Langerod H Johnsen AO Olsen E Skovlund AL Borresen-Dale 1998 p53 polymorphism and risk of cervical cancer Nature 396 530 531 10.1038/25034 10.1038/25034 1:CAS:528:DyaK1cXotVSqtb0%3D 9859987 (Pubitemid 28563706)
14. AM Josefsson PK Magnusson N Ylitalo P Quarforth-Tubbin J Ponten HO Adami UB Gyllensten 1998 p53 polymorphism and risk of cervical cancer Nature 396 531 10.1038/25037 10.1038/25037 1:CAS:528:DyaK1cXotVSqtbo%3D 9859988
15. A Hildesheim M Schiffman LA Brinton JF Fraumeni Jr R Herrero MC Bratti P Schwartz R Mortel W Barnes M Greenberg L McGowan DR Scott M Martin JE Herrera M Carrington 1998 p53 polymorphism and risk of cervical cancer Nature 396 531 532 10.1038/25040 10.1038/25040 1:CAS:528:DyaK1cXotVSqtbg%3D 9859989
16. Y Sonoda PE Saigo J Boyd 1999 p53 and genetic susceptibility to cervical cancer J Natl Cancer Inst 91 557 10.1093/jnci/91.6.557 10.1093/jnci/91.6.557 1:STN:280:DyaK1M7os1Crug%3D%3D 10088627
17. P Lauren 1965 The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification Acta Pathol Microbiol Scand 64 31 49 1:STN:280: DyaF2M7isFenug%3D%3D 14320675
18. CA Gonzalez N Sala G Capella 2002 Genetic susceptibility and gastric cancer risk Int J Cancer 100 249 260 10.1002/ijc.10466 10.1002/ijc.10466 1:CAS:528:DC%2BD38Xlt1Shsb4%3D 12115538 (Pubitemid 34728981)
19. P Correa 1992 Human gastric carcinogenesis: a multistep and multifactorial process Cancer Res 52 6735 6740 1:CAS:528:DyaK3sXjs1Orsw%3D%3D 1458460
20. GI Perez-Perez FJ Bosques-Padilla ML Crosatti R Tijerina-Menchaca E Garza-Gonzalez 2005 Role of p53 codon 72 polymorphism in the risk of development of distal gastric cancer Scand J Gastroenterol 40 56 60 10.1080/ 00365520410009456 10.1080/00365520410009456 1:CAS:528:DC%2BD2MXhvFGgurs%3D 15841715
21. H Shen A Solari X Wang Z Zhang Y Xu L Wang X Hu J Guo Q Wei 2004 p53 codon 72 polymorphism and risk of gastric cancer in a Chinese population Oncol Rep 11 1115 1120 1:CAS:528:DC%2BD2cXjslGksLo%3D 15069555
22. ZW Zhang P Newcomb A Hollowood GJ Moganaden R Feakins A Storey MJ Farthing D Alderson J Holly 2004 A comparison study of gastric cancer risk in patients with duodenal and gastric ulcer: roles of gastric mucosal histology and p53 codon 72 polymorphism Dig Dis Sci 49 254 259 10.1023/B:DDAS.0000017447. 02220.f5 10.1023/B:DDAS.0000017447.02220.f5 1:CAS:528:DC%2BD2cXhsFOhurk%3D 15104366 (Pubitemid 38392226)
23. WAF1/CIP1 haplotype in the intestinal gastric cancer and the precancerous lesions Carcinogenesis 25 2201 2206 10.1093/carcin/bgh229 10.1093/carcin/bgh229 1:CAS:528:DC%2BD2cXhtVWgs73K 15240512 (Pubitemid 39534858)
24. J Sul GP Yu QY Lu ML Lu VW Setiawan MR Wang CH Guo SZ Yu L Mu L Cai RC Kurtz ZF Zhang 2006 p53 codon 72 polymorphisms: a case-control study of gastric cancer and potential interactions Cancer Lett 238 210 223 10.1016/j.canlet.2005. 07.004 10.1016/j.canlet.2005.07.004 1:CAS:528:DC%2BD28XlvFGqsro%3D 16111803 (Pubitemid 43884957)
25. T Hiyama S Tanaka Y Kitadai M Ito M Sumii M Yoshihara F Shimamoto K Haruma K Chayama 2002 p53 codon 72 polymorphism in gastric cancer susceptibility in patients with Helicobacter pylori-associated chronic gastritis Int J Cancer 100 304 308 10.1002/ijc.10483 10.1002/ijc.10483 1:CAS:528:DC%2BD38Xlt1Shsbk%3D 12115545 (Pubitemid 34728988)
26. SJ Hessey J Spencer JI Wyatt G Sobala BJ Rathbone AT Axon MF Dixon 1990 Bacterial adhesion and disease activity in Helicobacter associated chronic gastritis Gut 31 134 138 10.1136/gut.31.2.134 10.1136/gut.31.2.134 1:STN:280:DyaK3c7osFertA%3D%3D 2311970
27. TL Cover MJ Blaser 1996 Helicobacter pylori infection, a paradigm for chronic mucosal inflammation: pathogenesis and implications for eradication and prevention Adv Intern Med 41 85 117 1:STN:280:DyaK2s%2FlvFaltA%3D%3D 8903587
28. BE Dunn H Cohen MJ Blaser 1997 Helicobacter pylori Clin Microbiol Rev 10 720 741 1:CAS:528:DyaK2sXmvFyhu7c%3D 9336670
29. A Labigne H de Reuse 1996 Determinants of Helicobacter pylori pathogenicity Infect Agents Dis 5 191 202 1:CAS:528:DyaK28Xmt1SjsL4%3D 8884364
30. HL Mobley 1997 Helicobacter pylori factors associated with disease development Gastroenterology 113 6 S21 S28 1:CAS:528:DyaK2sXotVymsL0%3D 9394755
31. DY Graham 1989 Campylobacter pylori and peptic ulcer disease Gastroenterology 96 2 pt 2 Suppl 615 625 1:STN:280:DyaL1M%2FnvV2htg%3D%3D 2642447
32. A Lee MF Dixon SJ Danon E Kuipers F Megraud H Larsson B Mellgard 1995 Local acid production and Helicobacter pylori: a unifying hypothesis of gastroduodenal disease Eur J Gastroenterol Hepatol 7 461 465 1:STN:280:DyaK2MzjvVylsw%3D%3D 7614109
33. KE McColl E el-Omar D Gillen 2000 Helicobacter pylori gastritis and gastric physiology Gastroenterol Clin North Am 29 687 703 10.1016/S0889-8553(05) 70138-2 10.1016/S0889-8553(05)70138-2 1:STN:280:DC%2BD3cvnvFamtg%3D%3D 11030081
34. LE Hansson O Nyren AW Hsing R Bergstrom S Josefsson WH Chow JF Fraumeni Jr HO Adami 1996 The risk of stomach cancer in patients with gastric or duodenal ulcer disease N Engl J Med 335 242 249 10.1056/NEJM199607253350404 10.1056/NEJM199607253350404 1:STN:280:DyaK283ms1ertA%3D%3D 8657240 (Pubitemid 26249572)
35. Y Mastumoto H Marusawa K Kinoshita Y Endo T Kou T Morisawa T Azuma IM Okazaki T Honjo T Chiba 2007 Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium Nat Med 13 470 476 10.1038/nm1566 10.1038/nm1566 (Pubitemid 46559833)
36. HE Gabbert W Muller A Schneiders S Meier G Hommel 1995 The relationship of p53 expression to the prognosis of 418 patients with gastric carcinoma Cancer 76 720 726 10.1002/1097-0142(19950901)76:5<720::AID-CNCR2820760503>3.0. CO;2-E 10.1002/1097-0142(19950901)76:5<720::AID-CNCR2820760503>3.0.CO;2-E 1:CAS:528:DyaK2MXosVejsL8%3D 8625172
37. MJ Brito GT Williams H Thompson MI Filippe 1994 Expression of p53 in early (T1) gastric carcinoma and precancerous adjacent mucosa Gut 35 1697 1700 10.1136/gut.35.12.1697 10.1136/gut.35.12.1697 1:STN:280:DyaK2M7ivF2qsQ%3D%3D 7829004
38. M Skacel RE Petras LA Rybicki TL Gramlich JE Richter GW Falk JR Goldblum 2002 p53 expression in low grade dysplasia in Barrett's esophagus: correlation with interobserver agreement and disease progression Am J Gastroenterol 97 2508 2513 10.1111/j.1572-0241.2002.06032.x 10.1111/j.1572-0241.2002.06032.x 1:CAS:528:DC%2BD38Xptlelt78%3D 12385431
39. M Younes A Erton LV Lechago JR Somoano J Lechago 1997 p53 protein accumulation is a specific marker of malignant potential in Barrett's metaplasia Dig Dis Sci 42 697 701 10.1023/A:1018828207371 10.1023/A:1018828207371 1:CAS:528:DyaK2sXjtFOitrk%3D 9125634
40. AP Weston SK Banerjee P Sharma TM Tran R Richards R Cherian 2001 p53 protein overexpression in low grade dysplasia (LGD) in Barrett's esophagus: immunohistological marker predictive of progression Am J Gastroenterol 96 1355 1362 10.1111/j.1572-0241.2001.03851.x 10.1111/j.1572-0241.2001.03851.x 1:CAS:528:DC%2BD3MXktlyisr4%3D 11374668
41. RJ Loffeld E Stobberingh JA Flendrig JW Arends 1991 Helicobacter pylori in gastric biopsy specimens. Comparison of culture, modified Giemsa stain, and immunohistochemistry. A retrospective study J Pathol 165 69 73 10.1002/path.1711650111 10.1002/path.1711650111 1:STN:280:DyaK38%2FmsFensw%3D%3D 1955938
42. MF Dixon RM Genta JH Yardley P Correa 1996 The participants on the International workshop on the Histopathology of Gastritis, Houston 1994. Classification and grading of gastritis: the Updated Sydney System Am J Surg Pathol 20 1161 1181 10.1097/00000478-199610000-00001 10.1097/00000478-199610000- 00001 1:STN:280:DyaK28visVGlsg%3D%3D 8827022 (Pubitemid 26336840)
43. SY Kim JS Ahn YJ Ha HJ Doh MH Jan SI Chung HJ Park 1998 Serodiagnosis of Helicobacter pylori infection in Korean patients using enzyme-linked immunosorbent assay J Immunoassay 19 251 270 10.1080/01971529808005485 10.1080/01971529808005485 1:CAS:528:DyaK1cXnslyrs7k%3D 9840297
44. M Thomas A Kalita S Labrecque D Pim L Banks G Matlashewski 1999 Two polymorphic variants of wild-type p53 differ biochemically and biologically Mol Cell Biol 19 1092 1100 1:CAS:528:DyaK1MXhtVKhsL0%3D 9891044
45. Y Zhou Z Li W Zhuang GJ Liu TX Wu X Yao L Du ML Wei XT Wu 2007 P53 codon 72 polymorphism and gastric cancer: a meta-analysis of the literature Int J Cancer 121 1481 1486 10.1002/ijc.22833 10.1002/ijc.22833 1:CAS:528: DC%2BD2sXhtVSns7%2FM 17546594 (Pubitemid 47328706)
46. JM Kim OY Lee CG Lee SJ Kwon KS Kim W Moon DH Koh HL Lee BC Yoon HS Choi JS Hahm MH Lee DH Lee 2007 p53 codon 72 and 16-bp duplication polymorphisms of gastric cancer in Koreans Korean J Gastroenterol 50 292 298 18159160
47. SJ Baker S Markowitz ER Fearon 1990 Suppression of human colorectal cell growth by wild-type p53 Science 249 912 915 10.1126/science.2144057 10.1126/science.2144057 1:STN:280:DyaK3czmsVCjuw%3D%3D 2144057
48. PW Hinds CA Finlay RS Quartin SJ Baker ER Fearon B Volgestein AJ Levine 1990 Mutant p53 DNA clones from human colon carcinomas cooperate with ras in transforming primary rat cells: a comparison of the 'hot' spot mutant phenotypes Cell Growth Differ 1 571 580 1:CAS:528:DyaK3MXmslant78%3D 2288874
49. SJ Kuerbitz BS Plunkett WV Walsh MB Kastan 1992 Wild-type p53 is a cell cycle check point determinant following irradiation Proc Natl Acad Sci USA 89 7491 7495 10.1073/pnas.89.16.7491 10.1073/pnas.89.16.7491 1:CAS:528: DyaK38Xls1Kkt7c%3D 1323840
50. LR Livingstone A White J Sprouse E Livanos T Jacks TD Tlsty 1992 Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53 Cell 70 923 935 10.1016/0092-8674(92)90243-6 10.1016/0092-8674(92)90243-6 1:CAS:528:DyaK3sXjs1yjsw%3D%3D 1356076
51. H Martin MI Filipe R Morris DP Lane F Silvestre 1992 p53 expression and prognosis in gastric carcinoma Int J Cancer 50 1 4 10.1002/ijc.2910500604 10.1002/ijc.2910500604
52. BV Joypaul EL Newman D Hopwood A Grant S Qureshi DP Lane A Cuschieri 1993 Expression of p53 protein in normal, dysplastic and malignant gastric mucosa: an immunohistochemical study J Pathol 170 279 283 10.1002/path.1711700310 1:STN:280:DyaK2c7otVantQ%3D%3D 8133401
53. F Segal AP Kaspary JC Prolla S Leistner 2004 p53 protein overexpression and p53 mutation analysis in patients with intestinal metaplasia of the cardia and Barrett's esophagus Cancer Lett 210 213 218 10.1016/j.canlet.2004.01.020 10.1016/j.canlet.2004.01.020 1:CAS:528:DC%2BD2cXks1Wrsbw%3D 15183537 (Pubitemid 38748692)
54. R Hamelin JF Flejou F Muzeau F Potet P Laurent-Puig F Fekete G Thomas 1994 Tp53 gene mutations and P53 protein immunoreactivity in malignant and premalignant Barretts-esophagus Gastroenterology 107 1012 1018 1:STN:280:DyaK2M%2FhtFagsw%3D%3D 7523212
55. G Coggi S Bosari M Roncalli D Graziani P Bossi G Viale R Buffa S Ferrero M Piazza S Blandamura 1997 p53 protein accumulation and p53 gene mutation in esophageal carcinoma-a molecular and immunochemical study with clinicopathologic correlations Cancer 79 425 432 10.1002/(SICI)1097-0142(19970201)79:3<425:: AID-CNCR1>3.0.CO;2-H 10.1002/(SICI)1097-0142(19970201)79:3<425::AID- CNCR1>3.0.CO;2-H 1:STN:280:DyaK2s7otVWktg%3D%3D 9028350 (Pubitemid 27051764)
56. YS Bian MC Osterheld FT Bosman J Benhattar C Fontolliet 2001 p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus Mod Pathol 14 397 403 10.1038/modpathol.3880324 10.1038/modpathol. 3880324 1:STN:280:DC%2BD3M3lsVyqtQ%3D%3D 11353048 (Pubitemid 32448736)
57. JH Moore EJ Lesser DH Erdody RB Matale MB Orringer DG Beer 1994 Intestinal differentiation and p53 gene alterations in Barrett's-esophagus and esophageal adenocarcinoma Int J Cancer 56 487 493 10.1002/ijc.2910560406 10.1002/ijc.2910560406 1:STN:280:DyaK2c7ls1Gisg%3D%3D 7906678
58. Munro AJ, Lain S, Lane DP. P53 abnormalities and outcomes in colorectal cancer: a systemic review. Br J Cancer. 2005;92:434-444.
59. DW Meek 2004 The p53 response to DNA damage DNA Repair (Amst) 3 1049 1056 10.1016/j.dnarep2004.03.027 10.1016/j.dnarep.2004.03.027 1:CAS:528: DC%2BD2cXmtVeqt7g%3D
60. L Murray A Sedo M Scott D McManus JM Sloan LJ Hardie D Forman CP Wild 2006 TP53 and progression from Barrett's metaplasia to oesophageal adenocarcinoma in a UK population cohort Gut 55 1390 1397 10.1136/gut.2005. 083295 10.1136/gut.2005.083295 1:CAS:528:DC%2BD28XhtFeht7zO 16682429 (Pubitemid 44476779)